Hematology is Equipped with independent bone‑marrow aspiration rooms, cell morphology laboratories and apheresis machines, the department adopts MICM detection and advanced immunological, molecular‑biological and cytogenetic assays to deliver standardized, precision‑based care for hematologic disorders. Conditions treated include cytopenias, acute/chronic leukemia, malignant lymphoma, multiple myeloma, myeloproliferative neoplasms, myelodysplastic syndromes, coagulopathies and rare hematologic diseases. Distinctive strengths cover individualized regimens for immune thrombocytopenia and elderly acute leukemia, targeted therapy, standardized lymphoma/myeloma management, translational research, novel immunotherapy, modified chemotherapy and hematopoietic stem‑cell transplantation. It provides tiered‑risk‑guided treatment, long‑term follow‑up and detailed disease monitoring, holding prominent regional advantages in comprehensive hematologic care.
Learn More